Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open-Label Safety and Efficacy Study of Reslizumab (CTx55700) for the Treatment of Pediatric Subjects With Eosinophilic Esophagitis Who Completed Study Res-5-0002
Brief Summary:
This study is an open-label study where all subjects will receive active drug, reslizumab. Subjects are able to enter this trial only through completion of study Res-05-0002 (NCT00538434).
The goal of the study is to show longer term safety and efficacy in pediatric subjects who have eosinophilic esophagitis.